Key Stakeholders Needed in the Development of Outpatient Naloxone Policies

Article
Conference|PAINWeek Conference

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.

Related Videos
Young depressed woman talking to lady psychologist during session, mental health - Image credit: motortion | stock.adobe.com
Related Content
naloxone concept represented by wooden letter tiles | Image Credit: lexiconimages - stock.adobe.com

FDA Approves Over-the-Counter Naloxone Nasal Spray for Opioid Overdose

April 25th 2024
Article
Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

April 5th 2024
Podcast
U.S. Food and Drug Administration FDA approved vector stamp | Image Credit: Calin - stock.adobe.com

FDA Approves Pivmecillinam for Treatment of Female Adults With Urinary Tract Infections

April 24th 2024
Article
Pharmacy Focus: OTC Contraception and Reproductive Health

Pharmacy Focus: OTC Contraception and Reproductive Health

March 29th 2024
Podcast
Serious thoughtful medical colleagues using digital tablet while viewing report together and discussing results standing by oxygen cylinders in laboratory- Image credit: Seventyfour | stock.adobe.com

Advocate for Greater Pharmacy Technician Roles

April 24th 2024
Article
Question mark made by white pills spilling out of brown glass bottle on pink background. Creative medicine for health/medical problem, drug interaction, medication error and pharmaceutical concept - Image credit: Orawan | stock.adobe.com

Accurate, Complete Data Entry Is Key to Medication Safety

April 24th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.